Therefore, the CDC20+KIF20A+PTTG1+ cell subpopulation featured aberrant oncogenic molecular activity in glioma, suggesting that these cells are therapeutically vulnerable to glioma progression. The gene discussed is PTTG1; the disease is glioma.